Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors
Shares of Bristol Myers Squibb Co. BMY slid 1.00% to $58.12 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.30% to 6,034.91 and Dow Jones Industrial Average DJIA falling 0.35% to 44,247.83.
Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies,
Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell?
Bristol Myers stock has witnessed a stupendous rally in the past six months. We believe there is more room for growth, and any dip in the share price can be used as a buying opportunity.
Bristol Myers Squibb Announces Dividend Increase
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company.
Bristol Myers (BMY) Upgraded to Buy: Here's Why
Bristol Myers Squibb (BMY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Why Did Bristol-Myers Squibb Co (BMY) Stock Surge 0.27% Last Week?
Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $59.38 which represents a slight increase of $0.54 or 0.92% from the prior close of $58.84. The stock opened at $58.84 and touched a low of $58.
Bristol Myers A Top Socially Responsible Dividend Stock With 4% Yield
The annualized dividend paid by Bristol Myers Squibb Co. is $2.4/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 10/04/2024
Bristol-Myers Squibb: Balancing Stability and Competition with Cautious Optimism
Analyst Evan Seigerman of BMO Capital maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report), retaining the price target of
Is Bristol-Myers Squibb Stock a Millionaire Maker?
Bristol-Myers Squibb (NYSE: BMY) is the kind of stock that potentially has a lot to offer to investors looking for wealth-building investments. With that in mind, let's examine this stock's potential as a millionaire maker.
Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors
This was the stock's third consecutive day of losses.
Bristol Myers raises quarterly dividend 3.3% to 62c per share
Squibb announced that its Board of Directors has declared a quarterly dividend of 62c per share on the 10c par value common ...
BofA restarts coverage of 11 large-cap biopharmas
BofA has reinstated coverage of 11 large-cap pharmaceutical and biotech stocks, with Eli Lilly (LLY), Gilead (GILD) and Merck ...
TipRanks on MSN3d
Bloomsbury Publishing Chairman Increases Shareholding
Bloomsbury Publishing (GB:BMY) has released an update. Bloomsbury Publishing’s Non-executive Chairman, John Bason, has increased his stake in the ...